June 14, 2016
Warner Chilcott PLC on Monday asked a Rhode Island federal court to dismiss revived claims that it paid drugmakers to delay producing a generic version of its contraceptive Loestrin in multidistrict litigation, saying the “kitchen sink” of antitrust allegations suffers from fatal deficiencies.
February 18, 2015
A Rhode Island judge on Tuesday cleared the way for Loestrin buyers to appeal the dismissal of their pay-for-delay claims against Warner Chilcott PLC, which would see another circuit court forced to decide whether patent settlements must include cash payments to face antitrust scrutiny.
September 04, 2014
A Rhode Island federal judge tossed all claims in multidistrict litigation that Warner Chilcott PLC and two others entered illegal agreements to delay generic versions of Loestrin, saying his decision "was not an easy one" but the deals didn't include cash payments as specified in the U.S. Supreme Court's Actavis ruling.